<DOC>
	<DOC>NCT02137694</DOC>
	<brief_summary>Auto-takings by APU and vaginal APV during the consultations for FCU in the department of gynecology-obstetrics (Group 1) according to an instructions for use proposed to the inclusive women, with consent; the same proposal, APU and APV, is made for other consultations requiring a screening on the CHRU (Group 2: dermatology, endocrinology, ambulatory surgery, inner medicine, pneumology, oncology). Auto-takings transmitted in the laboratory of the CHRU of Brest for test HPV by quantitative real-time PCR. Results transmitted to the women and to the doctors of consultation. In case of positive test (15 %), the patients are directed to a gynecologist. Confrontation with the cytological data when available (Group 1) .</brief_summary>
	<brief_title>Research for Papillomavirus as the Examination of Orientation in the Organized Screening of the Cervical Cancer</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>All the 2565yearold women requiring a screening and seen in consultation of the departments targeted by the CHRU of Brest Women except age limit, refusal to participate, hysterectomy, pregnancy and posttherapeutic followup.</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Papillomavirus</keyword>
	<keyword>Vaginal auto-takings</keyword>
	<keyword>Urinary test</keyword>
</DOC>